Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Novartis, Penn Unite on New Anticancer Path
Aug. 7, 2012
The drugmaker Novartis and the University of Pennsylvania announced a research and licensing agreement early Monday that aims to bring to market a new approach to fighting cancer that has shown promising results in early trials.
The New York Times
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing